765 related articles for article (PubMed ID: 21872624)
1. Transport of drugs across the blood-brain barrier by nanoparticles.
Wohlfart S; Gelperina S; Kreuter J
J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?
Kreuter J
Adv Drug Deliv Rev; 2014 May; 71():2-14. PubMed ID: 23981489
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
[TBL] [Abstract][Full Text] [Related]
4. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.
Andrieux K; Couvreur P
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(5):463-74. PubMed ID: 20049811
[TBL] [Abstract][Full Text] [Related]
5. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
[TBL] [Abstract][Full Text] [Related]
6. Drug delivery to the CNS and polymeric nanoparticulate carriers.
Costantino L
Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
[TBL] [Abstract][Full Text] [Related]
7. Polymeric nanoparticles for the drug delivery to the central nervous system.
Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
[TBL] [Abstract][Full Text] [Related]
8. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
9. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
10. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
11. Chapter 3 - Colloidal systems for CNS drug delivery.
Costantino L; Tosi G; Ruozi B; Bondioli L; Vandelli MA; Forni F
Prog Brain Res; 2009; 180():35-69. PubMed ID: 20302828
[TBL] [Abstract][Full Text] [Related]
12. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
[TBL] [Abstract][Full Text] [Related]
13. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
14. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis.
Ragnaill MN; Brown M; Ye D; Bramini M; Callanan S; Lynch I; Dawson KA
Eur J Pharm Biopharm; 2011 Apr; 77(3):360-7. PubMed ID: 21236340
[TBL] [Abstract][Full Text] [Related]
15. HI 6 human serum albumin nanoparticles--development and transport over an in vitro blood-brain barrier model.
Dadparvar M; Wagner S; Wien S; Kufleitner J; Worek F; von Briesen H; Kreuter J
Toxicol Lett; 2011 Sep; 206(1):60-6. PubMed ID: 21726608
[TBL] [Abstract][Full Text] [Related]
16. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.
Tosi G; Vergoni AV; Ruozi B; Bondioli L; Badiali L; Rivasi F; Costantino L; Forni F; Vandelli MA
J Control Release; 2010 Jul; 145(1):49-57. PubMed ID: 20338201
[TBL] [Abstract][Full Text] [Related]
17. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.
Tosi G; Costantino L; Rivasi F; Ruozi B; Leo E; Vergoni AV; Tacchi R; Bertolini A; Vandelli MA; Forni F
J Control Release; 2007 Sep; 122(1):1-9. PubMed ID: 17651855
[TBL] [Abstract][Full Text] [Related]
18. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
[TBL] [Abstract][Full Text] [Related]
19. Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.
Rempe R; Cramer S; Qiao R; Galla HJ
Cell Tissue Res; 2014 Mar; 355(3):717-26. PubMed ID: 24585360
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]